Sharif Shammaa
Medical · Rainelle, WVNPI 1497746416
Payments from drug & device makers
Across 108 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$473
- Lilly USA, LLC$289
- GSK$220
- Novartis$180
- Merck$154
- Novo Nordisk$128
- plus $427 from 12 others
What the payments were for
- Food & beverage$1,871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $473 |
| Lilly USA, LLC | 17 | $289 |
| GSK | 9 | $220 |
| Novartis | 10 | $180 |
| Merck | 10 | $154 |
| Novo Nordisk | 8 | $128 |
| Boehringer Ingelheim | 6 | $117 |
| Amgen | 4 | $63 |
| AstraZeneca | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $43 |
| Johnson & Johnson | 2 | $29 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Organogenesis Inc. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
How this compares
$1,871 in reported general payments places this provider in the 65th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 47 | $55,305 |
| EntrestoSacubitril/Valsartan | 34 | $54,229 |
| JardianceEmpagliflozin | 29 | $44,123 |
| EliquisApixaban | 35 | $40,810 |
| MounjaroTirzepatide | 18 | $31,348 |
| TrulicityDulaglutide | 14 | $28,762 |
| OzempicSemaglutide | 14 | $18,890 |
| Buprenorphine | 17 | $6,875 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,935 |
| Gabapentin | 111 | $1,446 |
| Omeprazole | 93 | $1,176 |
| Tramadol Hcl | 77 | $1,147 |
| Atorvastatin Calcium | 129 | $1,105 |
| Metoprolol Succinate | 81 | $1,061 |
| Fenofibrate | 11 | $1,003 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $289 | $60,11032 claims |
| AstraZenecaFarxiga | $48 | $55,30547 claims |
| NovartisEntresto | $180 | $54,22934 claims |
| Boehringer IngelheimJardiance | $117 | $44,12329 claims |
| PfizerEliquis | $17 | $40,81035 claims |
| Novo NordiskOzempic | $128 | $18,89014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 medical providers in West Virginia.
Other medical in Rainelle
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.